Skip to content

13F-HR filed by SAMSARA BIOCAPITAL, LLC

SAMSARA BIOCAPITAL, LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 57 holding rows worth $397,211,000.

Accession
0001104659-22-061327
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 57 entries on the cover page, a total value of $397,211,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $397,211,000 with VALUE read as thousands by filing date, 13F file number 028-19375. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CHINOOK THERAPEUTICS INC16961L106COM4,591,888$75,123,000thousands by filing date
GRAPHITE BIO INC38870X104COM8,072,603$41,170,000thousands by filing date
NKARTA INC65487U108COMMON STOCK2,034,702$23,155,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock1,991,950$21,413,000thousands by filing date
IVERIC BIO INC46583P102COM1,262,551$21,249,000thousands by filing date
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS1,884,096$16,900,000thousands by filing date
FORMA THERAPEUTICS HLDGS INC34633R104SHS1,565,526$14,559,000thousands by filing date
ARCELLX INC COMMON STOCK03940C100Stock999,727$14,016,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM1,675,579$13,773,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock794,171$13,692,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM640,688$10,424,000thousands by filing date
RAIN ONCOLOGY INC75082Q105COM1,571,379$7,967,000thousands by filing date
ZYMEWORKS INC98985W102COM970,987$6,360,000thousands by filing date
IO BIOTECH INC449778109COM1,120,437$5,938,000thousands by filing date
JANUX THERAPEUTICS INC47103J105COM411,871$5,906,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock480,000$5,832,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS1,111,112$5,544,000thousands by filing date
JIYA ACQUISITION CORP47760M102CMN507,041$4,984,000thousands by filing date
SCIENCE 37 HOLDINGS INC808644108COM900,000$4,815,000thousands by filing date
IMMUNOCORE HLDGS PLC ADS45258D105ADR160,963$4,813,000thousands by filing date
TANGO THERAPEUTICS INC87583X109COM630,000$4,775,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO659,409$4,504,000thousands by filing date
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK262,786$4,441,000thousands by filing date
SCHOLAR ROCK HLDG CORP80706P103COM339,611$4,378,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM228,466$4,371,000thousands by filing date
IGM BIOSCIENCES INC449585108COM154,664$4,134,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM345,293$3,978,000thousands by filing date
RECURSION PHARMACEUTICALS IN75629V104CL A539,236$3,861,000thousands by filing date
VIRACTA THERAPEUTICS INC92765F108COM711,039$3,385,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM59,204$3,341,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK100,000$2,983,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN300,000$2,961,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM1,049,153$2,875,000thousands by filing date
DECIBEL THERAPEUTICS INC24343R106COM826,422$2,512,000thousands by filing date
ELEVATION ONCOLOGY INC COM28623U101Stock932,240$2,349,000thousands by filing date
AMRYT PHARMA LTD - SPNR ADR03217L106COMMON EQUITY279,715$2,313,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM1,899,616$2,261,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM883,720$2,033,000thousands by filing date
Day One Biopharmaceuticals Inc23954D109Common Stock202,500$2,009,000thousands by filing date
NOVAVAX INC670002401COM NEW27,144$1,999,000thousands by filing date
EQUILLIUM INC29446K106COM615,541$1,939,000thousands by filing date
NOVAVAX INC670002401COM NEW23,400$1,723,000thousands by filing datecall
ATRECA INC04965G109COM396,835$1,258,000thousands by filing date
VTV THERAPEUTICS INC CL A918385105Stock1,635,509$1,181,000thousands by filing date
ALLAKOS INC01671P100COM172,089$981,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM700,421$925,000thousands by filing date
Surrozen, Inc.86889P109COM300,000$903,000thousands by filing date
TERNS PHARMACEUTICALS INC COM880881107Stock289,068$859,000thousands by filing date
KALA BIO INC COM483119103Stock601,162$830,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR4,031$688,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM40,550$643,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM488,632$606,000thousands by filing date
KRONOS BIO INC50107A104COM78,131$565,000thousands by filing date
ALLOVIR INC019818103COM82,336$556,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM13,669$208,000thousands by filing date
ASTRIA THERAPEUTICS INC COM04635X102Stock25,000$168,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW25,000$82,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-061327this filing2022-05-16acceptance time not in the bulk data set